Mark Fredric Cotton

32PUBLICATIONS
117CO-AUTHORS
Disease surveillanceNanotoxicology, health and safetyMajor global burdens of diseaseNorth American literatureAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 03, 2026
Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

|May 06, 2026
VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines.

|Apr 12, 2026
Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial.

James Wyncoll, Rujirek Kamolrattana, Moherndran Archary

|Jan 22, 2026
Reviewing the review.

Mark F Cotton, Andrew C Whitelaw, Ute Hallbauer

|Jan 16, 2026
HIV Cure Research: Ethical and Real-World Practical Considerations for Pediatric and Adolescent Populations.

Elise Tirza Ohene-Kyei, Jessica Salzwedel, Karine Dubé

|Nov 07, 2025
Postnatal HIV vertical transmission and the impact of infant feeding choice in the ART era.

Victoria Ndarukwa, Mark Cotton, Moleen Zunza

Pageof 6

Frequent Collaborators

5 joint publications

Barbara Laughton

5 joint publications

Shaun L Barnabas

4 joint publications

Lisa J Frigati

3 joint publications

Gert van Zyl